Trevi Therapeutics Inc. (TRVI)
Trevi Therapeutics Statistics
Share Statistics
Trevi Therapeutics has 101.75M shares outstanding. The number of shares has increased by 37.26% in one year.
| 101.75M |
| 37.26% |
| 8.19% |
| 78.67% |
| n/a |
| 9,203 |
| 0.35% |
Short Selling Information
The latest short interest is 6.87M, so 6.75% of the outstanding shares have been sold short.
| 6.87M |
| 6.75% |
| 8.08% |
| 6.42 |
Valuation Ratios
The PE ratio is -8.69 and the forward PE ratio is -11.76. Trevi Therapeutics's PEG ratio is -0.14.
| -8.69 |
| -11.76 |
| 0 |
| 2.7 |
| 4.18 |
| -10.87 |
| -0.14 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Trevi Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 10.41, with a Debt / Equity ratio of 0.01.
| 10.41 |
| 10.41 |
| 0.01 |
| -0.02 |
| -0.03 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,545,516.13 |
| 31 |
| 0 |
| n/a |
Taxes
| -30K |
| 0.06% |
Stock Price Statistics
The stock price has increased by 174.09% in the last 52 weeks. The beta is 0.53, so Trevi Therapeutics's price volatility has been higher than the market average.
| 0.53 |
| 174.09% |
| 6.29 |
| 4.37 |
| 57.35 |
| 2,630,639 |
Balance Sheet
The company has 34.1M in cash and 1.03M in debt, giving a net cash position of 33.06M.
| 34.1M |
| 1.03M |
| 33.06M |
| -287.05M |
| 107M |
| 98.75M |
Cash Flow
In the last 12 months, operating cash flow was -38.26M and capital expenditures -35K, giving a free cash flow of -38.29M.
| -38.26M |
| -35K |
| -38.29M |
| -0.38 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
TRVI does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for TRVI is $21, which is 210.2% higher than the current price. The consensus rating is "Buy".
| $21 |
| 210.2% |
| Buy |
| 9 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 47.17 |
| 2 |